Hosted by Merck, this training will cover high-quality life sciences career opportunities in North Carolina and provide strategies for connecting community members to these opportunities. Want to make ...

Join Women in Bio's Research Triangle Chapter for an afternoon of career exploration, direct hiring conversations, and meaningful relationship-building with some of the most innovative companies in ...

Durham-based GeneCentric Therapeutics, a cancer diagnostics company, has closed on an $8 million round of venture capital to launch and commercialize a novel liquid biopsy platform for guiding ...

This session is organized by GLOBE – Global Life Sciences Opportunities Business Exchange, an Intellectual Exchange Group with the North Carolina Biotechnology Center. GLOBE partners include the U.S.

Over the past year my colleague Nandini Mendu, Ph.D., senior director, agriculture sector development, has been working on a strategic project looking into North Carolina’s animal health and nutrition ...

Only five days after FDA approval of Yutrepia, Liquidia announced its first commercial shipment of the therapy, making prescriptions available to patients at specialty pharmacies. “We have moved with ...

Califf completed his second term as FDA commissioner in January with the change in administrations. He’s only the second ...

In an all-digital world, how can a more hands-on, personalized marketing and sales approach be leveraged to strengthen human connections?Come to this talk and discover how a personal touch can take ...

vTv Therapeutics, a biopharmaceutical company based in High Point, has received clearance from the U.S. Food and Drug Administration to resume clinical testing of a potential therapy for type 1 ...

Any bioscience or other technology company in North Carolina that has received a specified type of federal grant for research and development has until Dec. 1 to apply for matching state funds through ...